Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (569)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
152
2024
3035
11.040
Why?
Antibodies, Monoclonal
26
2024
562
6.310
Why?
Antineoplastic Agents
18
2024
1300
3.370
Why?
Antineoplastic Combined Chemotherapy Protocols
41
2024
1056
3.290
Why?
Hematopoietic Stem Cell Transplantation
26
2024
573
2.900
Why?
Humans
200
2024
54284
2.080
Why?
Monoclonal Gammopathy of Undetermined Significance
9
2023
108
1.960
Why?
Neoplasm Recurrence, Local
15
2024
644
1.930
Why?
Thalidomide
23
2019
397
1.930
Why?
Killer Cells, Natural
7
2020
107
1.810
Why?
Immunotherapy, Adoptive
8
2024
134
1.770
Why?
Interleukin-6
12
2023
315
1.750
Why?
Hematologic Neoplasms
3
2022
99
1.690
Why?
Neoplasm Proteins
13
2022
359
1.660
Why?
Antigens, Neoplasm
6
2014
170
1.530
Why?
Clinical Trials as Topic
13
2022
490
1.490
Why?
Stem Cell Transplantation
10
2022
196
1.440
Why?
Middle Aged
67
2022
13088
1.350
Why?
Prognosis
44
2024
2118
1.320
Why?
Gene Expression Regulation, Neoplastic
20
2022
866
1.320
Why?
Combined Modality Therapy
19
2024
692
1.320
Why?
Chromosomes, Human, Pair 1
9
2023
113
1.310
Why?
Herpesvirus 8, Human
7
2021
90
1.300
Why?
Translocation, Genetic
10
2022
287
1.240
Why?
Boronic Acids
12
2013
197
1.180
Why?
Pyrazines
12
2013
203
1.180
Why?
Treatment Outcome
46
2022
5604
1.130
Why?
Aged
67
2021
10054
1.130
Why?
Bone Marrow
18
2024
411
1.100
Why?
Immunotherapy
6
2024
263
1.040
Why?
Gene Expression Profiling
26
2023
1138
1.010
Why?
Disease-Free Survival
24
2019
485
0.990
Why?
Female
78
2021
28441
0.990
Why?
Adult
47
2022
14207
0.980
Why?
Male
75
2022
27334
0.970
Why?
Transplantation, Autologous
24
2024
476
0.970
Why?
T-Lymphocytes, Cytotoxic
4
2014
72
0.940
Why?
Melphalan
9
2020
180
0.940
Why?
B-Lymphocytes
4
2022
176
0.920
Why?
Cancer Vaccines
3
2010
103
0.900
Why?
Follow-Up Studies
26
2024
2387
0.890
Why?
Hyperhidrosis
1
2022
3
0.890
Why?
Plasma Cells
11
2023
238
0.890
Why?
Sweat
1
2022
7
0.880
Why?
Proteasome Inhibitors
4
2018
110
0.880
Why?
Antibodies, Bispecific
4
2024
43
0.870
Why?
Survival Rate
24
2020
951
0.850
Why?
Lymphoma, B-Cell
3
2022
62
0.840
Why?
Drug Approval
1
2022
47
0.840
Why?
Ehrlichia chaffeensis
1
2021
8
0.800
Why?
Patient Participation
1
2022
70
0.800
Why?
Cryosurgery
1
2021
38
0.790
Why?
Ehrlichiosis
1
2021
20
0.790
Why?
Immunoglobulin Light Chains
3
2017
101
0.770
Why?
T-Lymphocytes
8
2024
373
0.770
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
29
0.770
Why?
Dexamethasone
13
2024
435
0.760
Why?
B-Cell Maturation Antigen
6
2024
72
0.760
Why?
Embolization, Therapeutic
1
2021
98
0.740
Why?
Cell Proliferation
10
2023
1096
0.710
Why?
Disease Progression
16
2023
913
0.710
Why?
Chromosomal Instability
1
2019
17
0.710
Why?
Neoplasms, Plasma Cell
3
2024
39
0.690
Why?
Adrenal Cortex Hormones
2
2023
95
0.680
Why?
Membrane Proteins
3
2006
389
0.670
Why?
Immunologic Factors
2
2018
130
0.660
Why?
Neoplasm, Residual
8
2022
166
0.650
Why?
Epigenesis, Genetic
4
2023
399
0.650
Why?
POEMS Syndrome
1
2018
32
0.630
Why?
Chromosome Aberrations
12
2023
316
0.630
Why?
Dendritic Cells
3
2014
142
0.630
Why?
Atrial Fibrillation
2
2022
197
0.620
Why?
Survival Analysis
17
2023
735
0.620
Why?
Prealbumin
2
2014
24
0.610
Why?
Thyroid Neoplasms
1
2019
162
0.590
Why?
Receptors, Interleukin-6
2
2014
29
0.580
Why?
Antibodies, Monoclonal, Humanized
6
2023
240
0.580
Why?
Positron-Emission Tomography
7
2022
322
0.570
Why?
Cardiomyopathies
2
2014
129
0.540
Why?
Osteolysis
4
2022
88
0.510
Why?
Mutation
10
2022
1501
0.500
Why?
Immunotoxins
1
2014
5
0.500
Why?
Cytotoxicity, Immunologic
2
2012
62
0.490
Why?
Clonal Evolution
3
2020
60
0.480
Why?
Practice Guidelines as Topic
4
2023
492
0.460
Why?
Cyclophosphamide
5
2021
172
0.460
Why?
Transplantation, Homologous
5
2017
155
0.460
Why?
Amyloidosis
1
2014
85
0.450
Why?
Tumor Microenvironment
5
2023
209
0.440
Why?
Aged, 80 and over
17
2021
3431
0.440
Why?
Health Status
1
2015
368
0.440
Why?
Fluorodeoxyglucose F18
6
2021
205
0.430
Why?
Remission Induction
13
2021
221
0.430
Why?
Neutropenia
2
2023
120
0.420
Why?
Receptors, KIR
2
2008
15
0.420
Why?
Risk Factors
18
2021
3935
0.410
Why?
Polymorphism, Single Nucleotide
2
2020
552
0.400
Why?
Pyrimidines
2
2022
196
0.400
Why?
Bone Diseases
3
2021
109
0.390
Why?
Azacitidine
1
2010
37
0.390
Why?
Thrombocytopenia
2
2022
99
0.390
Why?
Dose-Response Relationship, Drug
8
2020
1476
0.390
Why?
Benzamides
1
2010
54
0.390
Why?
Evolution, Molecular
2
2021
103
0.380
Why?
Recurrence
11
2021
690
0.380
Why?
Histone Deacetylase Inhibitors
1
2010
56
0.380
Why?
C-Reactive Protein
6
2022
159
0.370
Why?
Prednisone
2
2021
111
0.370
Why?
Doxorubicin
6
2021
259
0.360
Why?
TOR Serine-Threonine Kinases
2
2020
85
0.350
Why?
Drug Administration Schedule
5
2015
401
0.350
Why?
Chromosome Deletion
5
2023
150
0.350
Why?
Metaphase
4
2016
55
0.340
Why?
Vaccination
4
2022
294
0.340
Why?
Pelvis
2
2021
76
0.340
Why?
Membrane Glycoproteins
2
2009
269
0.330
Why?
Quality of Life
1
2015
922
0.330
Why?
Paraproteinemias
3
2022
80
0.330
Why?
Proportional Hazards Models
7
2024
431
0.320
Why?
Placebo Effect
2
2020
19
0.320
Why?
Bone Neoplasms
4
2013
193
0.320
Why?
Adoptive Transfer
1
2007
38
0.310
Why?
Histocompatibility Antigens Class I
1
2007
52
0.310
Why?
Chromatin
3
2023
156
0.310
Why?
Cytogenetic Analysis
5
2023
90
0.300
Why?
DNA Methylation
4
2023
574
0.300
Why?
Animals
14
2024
14385
0.290
Why?
Drug Resistance, Neoplasm
6
2021
309
0.290
Why?
Vincristine
3
2021
98
0.290
Why?
Mice, SCID
6
2013
196
0.290
Why?
Risk Assessment
9
2022
1361
0.280
Why?
Cell Membrane
1
2007
278
0.280
Why?
In Situ Hybridization, Fluorescence
5
2023
278
0.280
Why?
Down-Regulation
1
2007
388
0.280
Why?
Angiogenesis Inhibitors
5
2010
203
0.280
Why?
Neoplasm Staging
6
2024
806
0.270
Why?
Chromosomes, Human, Pair 17
2
2017
43
0.270
Why?
Transplantation Conditioning
5
2008
86
0.270
Why?
Disease Management
2
2018
184
0.270
Why?
Cell Line, Tumor
9
2023
1550
0.260
Why?
Infusions, Intravenous
3
2015
231
0.260
Why?
Bone Resorption
2
2022
326
0.260
Why?
Antibody Formation
1
2005
69
0.260
Why?
Fever
2
2022
129
0.250
Why?
Polycomb Repressive Complex 2
2
2021
50
0.250
Why?
CD8-Positive T-Lymphocytes
2
2020
116
0.250
Why?
Pentaerythritol Tetranitrate
1
2024
6
0.250
Why?
Monocytes
2
2020
156
0.240
Why?
Flow Cytometry
4
2012
546
0.240
Why?
Time Factors
11
2021
3213
0.230
Why?
Gene Expression
2
2018
664
0.230
Why?
High-Throughput Nucleotide Sequencing
3
2022
206
0.230
Why?
Epstein-Barr Virus Infections
2
2020
34
0.230
Why?
Proteasome Endopeptidase Complex
3
2011
131
0.230
Why?
Cell Cycle Proteins
2
2022
199
0.230
Why?
Chromans
1
2024
62
0.230
Why?
Integrin beta Chains
1
2023
14
0.230
Why?
Blotting, Western
3
2015
683
0.230
Why?
Mice
10
2024
6413
0.230
Why?
Integrins
1
2023
36
0.230
Why?
Signal Transduction
6
2021
1753
0.220
Why?
Prospective Studies
8
2022
2604
0.220
Why?
Double-Blind Method
2
2015
742
0.220
Why?
Sweating
1
2022
19
0.220
Why?
Cross-Sectional Studies
3
2023
1693
0.220
Why?
Young Adult
5
2020
4318
0.220
Why?
Consensus
2
2020
157
0.210
Why?
Radiation-Protective Agents
1
2024
116
0.210
Why?
Case-Control Studies
5
2019
1228
0.210
Why?
DNA, Intergenic
1
2022
6
0.210
Why?
Proto-Oncogene Proteins B-raf
2
2020
90
0.210
Why?
Immunoconjugates
1
2022
38
0.210
Why?
Receptors, Antigen, T-Cell
1
2022
50
0.210
Why?
Tumor Cells, Cultured
4
2013
477
0.210
Why?
Kaplan-Meier Estimate
10
2016
514
0.210
Why?
Tumor Suppressor Protein p53
2
2017
250
0.210
Why?
Waldenstrom Macroglobulinemia
1
2022
41
0.210
Why?
United States Food and Drug Administration
1
2022
97
0.210
Why?
Proteomics
3
2021
343
0.210
Why?
Epigenomics
1
2021
67
0.200
Why?
Mediastinum
1
2021
27
0.200
Why?
Chromosomes, Human, Pair 14
3
2020
76
0.200
Why?
Receptors, Glucocorticoid
2
2012
36
0.200
Why?
United States
4
2022
5217
0.200
Why?
Registries
2
2022
553
0.200
Why?
Ubiquitination
1
2021
47
0.200
Why?
Influenza, Human
1
2022
120
0.200
Why?
Phosphatidylinositol 3-Kinases
2
2019
153
0.200
Why?
Axilla
1
2021
101
0.200
Why?
Genetic Predisposition to Disease
2
2022
570
0.200
Why?
Multiple Organ Failure
1
2021
56
0.200
Why?
Alleles
3
2021
277
0.200
Why?
Salvage Therapy
6
2013
145
0.190
Why?
Proto-Oncogene Proteins c-maf
2
2020
20
0.190
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.190
Why?
Diffusion Magnetic Resonance Imaging
2
2019
126
0.190
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.190
Why?
Rare Diseases
1
2020
46
0.190
Why?
Genome-Wide Association Study
2
2020
190
0.190
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
105
0.190
Why?
Interferon-gamma
3
2014
195
0.190
Why?
Apoptosis
5
2018
1300
0.190
Why?
Genes, Tumor Suppressor
2
2021
85
0.190
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
14
0.180
Why?
Leukemia, Plasma Cell
1
2020
34
0.180
Why?
Myelodysplastic Syndromes
2
2013
79
0.180
Why?
Interferon Type I
1
2020
30
0.180
Why?
Radiopharmaceuticals
4
2021
238
0.180
Why?
Cytokines
2
2014
676
0.180
Why?
Cell Cycle
1
2021
275
0.180
Why?
Research Design
2
2020
374
0.180
Why?
Gene Amplification
1
2019
57
0.180
Why?
Measles virus
1
2019
9
0.180
Why?
Multivariate Analysis
8
2021
643
0.180
Why?
Hematopoiesis, Extramedullary
1
2019
10
0.180
Why?
Measles
1
2019
9
0.180
Why?
Genomics
4
2023
310
0.180
Why?
Gene Regulatory Networks
1
2020
124
0.180
Why?
Oncolytic Virotherapy
1
2019
18
0.180
Why?
Health Status Disparities
1
2022
219
0.170
Why?
Data Collection
1
2020
321
0.170
Why?
Immunohistochemistry
2
2015
1089
0.170
Why?
DNA
1
2023
581
0.170
Why?
Sirolimus
1
2019
65
0.170
Why?
Patient Safety
1
2020
121
0.170
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
11
0.170
Why?
Healthcare Disparities
1
2022
271
0.170
Why?
Biopsy
5
2018
692
0.170
Why?
Syndrome
1
2019
252
0.170
Why?
Precancerous Conditions
2
2010
93
0.170
Why?
Proto-Oncogene Proteins c-akt
1
2019
176
0.170
Why?
Graft vs Host Disease
4
2007
83
0.170
Why?
Evidence-Based Medicine
2
2018
281
0.170
Why?
MafB Transcription Factor
1
2018
11
0.170
Why?
Cell Differentiation
6
2022
720
0.170
Why?
Spleen
1
2019
186
0.160
Why?
Genomic Instability
2
2016
95
0.160
Why?
Phosphotransferases
1
2018
24
0.160
Why?
Immunomodulation
1
2018
42
0.160
Why?
Plasma
1
2018
52
0.160
Why?
Myeloablative Agonists
2
2008
33
0.160
Why?
Chemokines
1
2018
96
0.160
Why?
Hematopoietic Stem Cell Mobilization
2
2008
61
0.160
Why?
Genes, Neoplasm
2
2015
36
0.160
Why?
Adipocytes
1
2018
129
0.160
Why?
Osteoclasts
3
2022
469
0.150
Why?
Gene Dosage
2
2015
91
0.150
Why?
Gene Rearrangement
1
2018
76
0.150
Why?
Magnetic Resonance Imaging
5
2013
1604
0.150
Why?
Hexokinase
1
2017
18
0.150
Why?
Heterozygote
2
2014
96
0.150
Why?
Communication
1
2019
273
0.150
Why?
HLA-A Antigens
2
2007
13
0.150
Why?
Calcification, Physiologic
1
2017
42
0.150
Why?
Models, Biological
2
2018
823
0.150
Why?
Protein-Tyrosine Kinases
2
2018
101
0.150
Why?
Drug Therapy, Combination
1
2018
426
0.140
Why?
Gene Frequency
2
2013
120
0.140
Why?
Oligonucleotide Array Sequence Analysis
5
2010
474
0.140
Why?
Syndecan-1
4
2021
82
0.140
Why?
Transcriptome
4
2020
346
0.140
Why?
Confidence Intervals
2
2014
167
0.140
Why?
Lymphocyte Activation
2
2017
197
0.140
Why?
Tumor Burden
3
2020
142
0.140
Why?
Immunity, Innate
1
2016
114
0.140
Why?
Erythrocyte Indices
1
2015
8
0.140
Why?
Biomarkers, Pharmacological
2
2012
28
0.140
Why?
Gene Expression Regulation, Enzymologic
1
2017
206
0.130
Why?
DNA Copy Number Variations
3
2022
114
0.130
Why?
Adolescent
5
2020
6897
0.130
Why?
Critical Illness
1
2018
344
0.130
Why?
Coculture Techniques
2
2013
160
0.130
Why?
Hemoglobins
2
2013
126
0.130
Why?
Cysteine-Rich Protein 61
1
2014
4
0.130
Why?
Hematologic Diseases
1
2014
25
0.120
Why?
Half-Life
1
2014
92
0.120
Why?
International Cooperation
1
2014
63
0.120
Why?
Fatigue
1
2015
129
0.120
Why?
Area Under Curve
1
2014
205
0.120
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
314
0.120
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.120
Why?
Iron
1
2015
158
0.120
Why?
ROC Curve
1
2014
259
0.120
Why?
Antineoplastic Agents, Alkylating
3
2008
74
0.120
Why?
Antibodies
2
2024
178
0.120
Why?
Reference Values
1
2014
354
0.120
Why?
Emotions
1
2015
168
0.120
Why?
Administration, Metronomic
1
2013
7
0.120
Why?
Neoplasms, Glandular and Epithelial
1
2014
48
0.120
Why?
Cystatin M
2
2024
21
0.120
Why?
Renal Insufficiency
2
2021
138
0.120
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.110
Why?
Central Nervous System Neoplasms
1
2013
57
0.110
Why?
Severity of Illness Index
2
2014
1084
0.110
Why?
Inflammation Mediators
1
2014
128
0.110
Why?
Retrospective Studies
7
2024
6432
0.110
Why?
beta Catenin
1
2013
102
0.110
Why?
Disease Models, Animal
2
2016
1639
0.110
Why?
Oligopeptides
1
2013
95
0.110
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
15
0.110
Why?
Cisplatin
4
2013
352
0.110
Why?
Myelolipoma
1
2012
10
0.110
Why?
Leukemia
1
2013
69
0.110
Why?
Lymph Nodes
3
2021
284
0.110
Why?
Venous Thrombosis
2
2004
102
0.110
Why?
Mental Health
1
2015
245
0.110
Why?
Interleukin Receptor Common gamma Subunit
1
2012
10
0.110
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
11
0.110
Why?
Maintenance Chemotherapy
1
2012
48
0.110
Why?
Clone Cells
2
2023
89
0.110
Why?
Cell Survival
2
2020
657
0.110
Why?
Interleukin-2
1
2012
75
0.110
Why?
Mice, Inbred NOD
1
2012
99
0.100
Why?
Cell Movement
1
2013
271
0.100
Why?
Vascular Endothelial Growth Factor A
1
2013
230
0.100
Why?
Immunoenzyme Techniques
1
2012
165
0.100
Why?
Hemangioma
1
2013
83
0.100
Why?
Pain
1
2015
405
0.100
Why?
Models, Genetic
2
2016
209
0.100
Why?
Neoplasms, Second Primary
1
2012
77
0.100
Why?
Soft Tissue Neoplasms
1
2012
65
0.100
Why?
Genotype
1
2013
599
0.100
Why?
Arkansas
5
2021
2100
0.100
Why?
Transduction, Genetic
2
2014
50
0.100
Why?
Chemokine CXCL13
2
2022
4
0.100
Why?
Transcriptional Elongation Factors
2
2022
28
0.100
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
57
0.100
Why?
Mutation Rate
2
2021
40
0.100
Why?
CD40 Ligand
1
2010
15
0.100
Why?
Immunoglobulin Idiotypes
1
2010
18
0.100
Why?
Hypersensitivity, Delayed
1
2010
21
0.100
Why?
Models, Statistical
2
2014
259
0.090
Why?
Interleukin-4
1
2010
48
0.090
Why?
Secondary Prevention
1
2010
89
0.090
Why?
HIV Seropositivity
1
2010
28
0.090
Why?
Eukaryotic Initiation Factor-2
1
2010
18
0.090
Why?
Immunity, Cellular
1
2010
80
0.090
Why?
Adjuvants, Immunologic
1
2010
61
0.090
Why?
Up-Regulation
4
2018
508
0.090
Why?
Etoposide
2
2007
85
0.090
Why?
Transplantation, Heterologous
1
2009
77
0.090
Why?
Cell Line
2
2013
1153
0.090
Why?
Cells, Cultured
3
2013
1737
0.090
Why?
Placenta
1
2011
135
0.090
Why?
Ovarian Neoplasms
1
2014
472
0.090
Why?
Longitudinal Studies
3
2020
746
0.080
Why?
Cytotoxicity Tests, Immunologic
1
2008
31
0.080
Why?
Radiography
4
2012
524
0.080
Why?
Histones
2
2021
335
0.080
Why?
Polymerase Chain Reaction
1
2010
531
0.080
Why?
Lymphocyte Subsets
1
2008
13
0.080
Why?
Immunoglobulin lambda-Chains
1
2008
18
0.080
Why?
Granulocyte Colony-Stimulating Factor
1
2008
69
0.080
Why?
Cytogenetics
1
2008
28
0.080
Why?
Bone and Bones
3
2021
516
0.080
Why?
Haplotypes
1
2008
105
0.080
Why?
Receptors, Immunologic
1
2008
37
0.080
Why?
Transcription Factors
2
2023
622
0.080
Why?
Liver Neoplasms
1
2012
352
0.080
Why?
Gene Deletion
1
2009
293
0.080
Why?
Neoplastic Stem Cells
1
2009
103
0.080
Why?
Ligands
1
2008
230
0.080
Why?
Twins
1
2007
32
0.080
Why?
Osteogenesis
1
2011
377
0.080
Why?
Busulfan
1
2007
18
0.080
Why?
Herpesviridae Infections
2
2019
46
0.080
Why?
Immunophenotyping
1
2007
117
0.080
Why?
Diphosphonates
1
2008
96
0.080
Why?
Leukocytes, Mononuclear
1
2007
133
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Caspases
2
2018
146
0.070
Why?
Creatinine
1
2007
169
0.070
Why?
Blood Proteins
1
2007
100
0.070
Why?
Antibodies, Neoplasm
1
2006
35
0.070
Why?
Graft vs Leukemia Effect
1
2006
2
0.070
Why?
Chromosome Banding
1
2006
28
0.070
Why?
Immunosuppressive Agents
1
2008
248
0.070
Why?
Plasmacytoma
1
2006
47
0.070
Why?
Skin Neoplasms
1
2012
532
0.070
Why?
HLA-A2 Antigen
1
2005
12
0.070
Why?
Amiloride
1
2005
14
0.070
Why?
Cohort Studies
3
2020
1543
0.070
Why?
MicroRNAs
1
2010
386
0.070
Why?
Bone Marrow Transplantation
2
2022
149
0.070
Why?
Imaging, Three-Dimensional
2
2017
171
0.070
Why?
Poly(ADP-ribose) Polymerases
2
2016
43
0.060
Why?
Sensitivity and Specificity
1
2007
923
0.060
Why?
Predictive Value of Tests
3
2018
1048
0.060
Why?
Enoxaparin
1
2004
25
0.060
Why?
Ferritins
1
2024
31
0.060
Why?
Myeloid Progenitor Cells
1
2023
19
0.060
Why?
X-Ray Microtomography
1
2024
82
0.060
Why?
NF-kappa B
2
2018
335
0.060
Why?
Macaca mulatta
1
2024
106
0.060
Why?
Receptors, G-Protein-Coupled
1
2024
55
0.060
Why?
Epidemiologic Methods
3
2008
49
0.060
Why?
Gene Silencing
2
2016
129
0.060
Why?
DNA, Neoplasm
2
2020
171
0.060
Why?
Fibroblasts
1
2005
386
0.060
Why?
Neoplasms
1
2014
1316
0.060
Why?
Cell Communication
1
2023
72
0.060
Why?
Cluster Analysis
3
2010
249
0.060
Why?
TNF Receptor-Associated Factor 3
1
2022
14
0.060
Why?
Vitamin E
1
2024
107
0.050
Why?
Patients
1
2022
53
0.050
Why?
Geography
1
2022
81
0.050
Why?
Guanine Nucleotide Exchange Factors
1
2022
17
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
40
0.050
Why?
Inheritance Patterns
1
2022
27
0.050
Why?
Quantitative Trait Loci
1
2022
51
0.050
Why?
Primary Cell Culture
1
2022
65
0.050
Why?
Oncogenes
1
2021
63
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2022
44
0.050
Why?
Risk
2
2014
343
0.050
Why?
Patient Selection
1
2023
286
0.050
Why?
Age of Onset
2
2013
117
0.050
Why?
Anticoagulants
1
2004
270
0.050
Why?
Phylogeny
1
2022
269
0.050
Why?
RANK Ligand
1
2022
183
0.050
Why?
Boron Compounds
1
2021
18
0.050
Why?
SOXC Transcription Factors
1
2021
14
0.050
Why?
Child, Preschool
2
2020
4147
0.050
Why?
Polymorphism, Genetic
1
2022
193
0.050
Why?
Transcriptional Activation
1
2021
134
0.050
Why?
Rabbits
2
2013
425
0.050
Why?
Adaptor Proteins, Signal Transducing
1
2022
208
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.050
Why?
Glycine
1
2021
70
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Spatio-Temporal Analysis
1
2020
10
0.050
Why?
Aneuploidy
1
2020
23
0.050
Why?
Edema
1
2021
74
0.050
Why?
Fibrosis
1
2021
208
0.050
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.050
Why?
Gene Expression Regulation, Leukemic
1
2020
36
0.050
Why?
Histone Code
1
2020
32
0.050
Why?
Cyclin D1
1
2020
60
0.050
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.050
Why?
Base Sequence
1
2022
719
0.050
Why?
ras Proteins
1
2020
70
0.050
Why?
Repressor Proteins
1
2022
165
0.050
Why?
Protein Kinase Inhibitors
1
2022
216
0.050
Why?
Genome, Human
1
2021
131
0.050
Why?
Single-Cell Analysis
1
2020
56
0.050
Why?
Genetic Loci
1
2020
58
0.040
Why?
False Negative Reactions
1
2019
36
0.040
Why?
Herpesvirus 4, Human
1
2019
38
0.040
Why?
Neoplasm Invasiveness
1
2020
295
0.040
Why?
Mice, Transgenic
1
2021
656
0.040
Why?
DNA Mutational Analysis
1
2020
217
0.040
Why?
Europe
1
2019
102
0.040
Why?
Incidence
2
2013
1082
0.040
Why?
Genetic Variation
1
2020
253
0.040
Why?
Communicable Disease Control
1
2019
39
0.040
Why?
beta 2-Microglobulin
2
2009
35
0.040
Why?
Virus Diseases
1
2019
44
0.040
Why?
Genome, Viral
1
2019
100
0.040
Why?
Computational Biology
1
2020
231
0.040
Why?
DNA, Viral
1
2019
142
0.040
Why?
Fibrinogen
1
2018
37
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
21
0.040
Why?
Immunoglobulin A
1
2018
54
0.040
Why?
RNA, Messenger
2
2016
1202
0.040
Why?
Platelet Count
2
2008
77
0.040
Why?
Bone Marrow Cells
2
2014
233
0.040
Why?
Hospitalization
1
2022
705
0.040
Why?
Pathology, Molecular
1
2018
24
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
Why?
Oncogene Proteins, Fusion
1
2018
60
0.040
Why?
DNA-Binding Proteins
1
2021
462
0.040
Why?
Databases, Factual
2
2013
684
0.040
Why?
Immunoglobulin G
1
2018
226
0.040
Why?
Data Interpretation, Statistical
2
2010
177
0.040
Why?
Promoter Regions, Genetic
1
2020
520
0.040
Why?
Kidney Function Tests
1
2017
59
0.040
Why?
False Positive Reactions
1
2017
68
0.040
Why?
Child
2
2020
7341
0.040
Why?
Lamins
1
2016
6
0.040
Why?
Chromosomes, Human, Pair 16
1
2016
20
0.040
Why?
Glomerular Filtration Rate
1
2017
138
0.040
Why?
Internationality
1
2017
49
0.040
Why?
Cell Transformation, Neoplastic
1
2018
200
0.040
Why?
Alkaline Phosphatase
1
2017
99
0.040
Why?
Genes, ras
1
2016
48
0.040
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
74
0.040
Why?
Genes, p53
1
2016
60
0.040
Why?
Amino Acid Sequence
1
2018
767
0.040
Why?
Glycolysis
1
2016
73
0.040
Why?
Proteolysis
1
2016
102
0.030
Why?
Chromosome Mapping
2
2006
175
0.030
Why?
Enzyme Activation
1
2016
329
0.030
Why?
Prevalence
1
2019
1025
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
119
0.030
Why?
Phosphorylation
1
2016
614
0.030
Why?
Gene Fusion
1
2014
14
0.030
Why?
Asymptomatic Diseases
1
2014
43
0.030
Why?
Interspersed Repetitive Sequences
1
2014
10
0.030
Why?
Karyotype
1
2014
19
0.030
Why?
Capsid
1
2014
3
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
8
0.030
Why?
Myocardium
1
2017
441
0.030
Why?
Kidney Diseases
1
2017
293
0.030
Why?
HIV-1
1
2014
72
0.030
Why?
Homozygote
1
2013
60
0.030
Why?
Cerebrospinal Fluid
1
2013
35
0.030
Why?
Nicotinamide Mononucleotide
1
2013
4
0.030
Why?
Acrylamides
1
2013
8
0.030
Why?
Genetic Vectors
1
2014
139
0.030
Why?
Receptors, CXCR4
1
2013
31
0.030
Why?
Chemokine CXCL12
1
2013
31
0.030
Why?
NAD
1
2013
46
0.030
Why?
Niacinamide
1
2013
25
0.030
Why?
Dependovirus
1
2014
102
0.030
Why?
Enzyme Induction
1
2013
80
0.030
Why?
Sirtuin 1
1
2013
29
0.030
Why?
Amides
1
2013
43
0.030
Why?
Diagnosis, Differential
1
2017
1136
0.030
Why?
Transplantation Chimera
2
2003
15
0.030
Why?
Gene Knockdown Techniques
1
2013
125
0.030
Why?
Nitriles
1
2013
69
0.030
Why?
RNA, Small Interfering
1
2013
252
0.030
Why?
Piperidines
1
2013
103
0.030
Why?
Induction Chemotherapy
1
2012
59
0.030
Why?
Lymphocyte Count
1
2011
23
0.030
Why?
Chemokine CXCL10
1
2011
20
0.030
Why?
Acute Disease
1
2013
403
0.030
Why?
Infant
1
2020
3817
0.030
Why?
HIV Infections
1
2016
394
0.030
Why?
Antibodies, Neutralizing
1
2011
75
0.030
Why?
Tomography, X-Ray Computed
1
2017
1213
0.020
Why?
Pharmacogenetics
1
2011
55
0.020
Why?
Sex Factors
1
2013
767
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
30
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
48
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
51
0.020
Why?
Microarray Analysis
1
2010
84
0.020
Why?
International Classification of Diseases
1
2010
65
0.020
Why?
Argonaute Proteins
1
2010
11
0.020
Why?
Enzyme Inhibitors
1
2013
446
0.020
Why?
RNA-Binding Proteins
1
2011
136
0.020
Why?
Oligonucleotides
1
2010
76
0.020
Why?
Polyploidy
1
2009
11
0.020
Why?
Bone Marrow Examination
1
2009
12
0.020
Why?
L-Lactate Dehydrogenase
1
2009
79
0.020
Why?
Hematopoietic Stem Cells
1
2011
215
0.020
Why?
Ploidies
1
2008
13
0.020
Why?
Neoplasm Metastasis
1
2009
252
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
41
0.020
Why?
Serum Albumin
1
2008
62
0.020
Why?
Polyethylene Glycols
1
2008
106
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
219
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
596
0.020
Why?
Age Distribution
1
2007
198
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
Why?
Multigene Family
1
2006
54
0.020
Why?
Recombinant Proteins
1
2008
569
0.020
Why?
Cyclin D
1
2006
20
0.020
Why?
Syndecans
1
2006
43
0.020
Why?
RNA, Neoplasm
1
2006
54
0.020
Why?
Cyclins
1
2006
54
0.020
Why?
Proteoglycans
1
2006
96
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
191
0.020
Why?
Brain
1
2013
1387
0.020
Why?
Survivors
1
2006
137
0.020
Why?
Pregnancy
1
2011
2620
0.010
Why?
Lymphocyte Transfusion
1
2003
12
0.010
Why?
Probability
1
2003
176
0.010
Why?
Administration, Oral
1
2003
459
0.010
Why?
Tissue Donors
1
2003
110
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description